about
Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packagingA single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs.Creation of a nonspreading Rift Valley fever virusCo-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission.Paramyxovirus-based production of Rift Valley fever virus replicon particles.Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells.Preliminary Evaluation of a Bunyavirus Vector for Cancer Immunotherapy.Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen.Comparative efficacy of two next-generation Rift Valley fever vaccines.Efficacy of three candidate Rift Valley fever vaccines in sheep.SARS-CoV2 infection in farmed mink, Netherlands, April 2020The deubiquitinating activity of Middle East respiratory syndrome coronavirus papain-like protease delays the innate immune response and enhances virulence in a mouse model
P50
Q34262159-8CC950E4-C0D4-4301-932D-43C81C4E38C6Q35027744-A5A26AFF-D5C6-4039-8BB3-2798F882B046Q35531617-E68FFA44-F375-4541-ADB5-B210481B01EAQ38802340-994F6B73-0C9C-4563-ACD8-04064E199F3BQ38957617-691E029F-5E02-4706-847A-6B52A2CCA728Q40130716-8704186F-AA1C-4F45-B0B8-ACB3C058BA41Q40151111-8581D6E2-AF0F-4376-863B-4E70741C3E91Q40198870-8CE82C9E-AA68-4C6E-80B3-B467FE4AF8D8Q40199478-8D77CCF0-AAC9-4CB7-BC34-112491BB5B13Q40292321-66A55AA7-DC4B-47DE-8BED-C1C554160D8DQ95627287-34EC08DE-CA60-4F8C-8DC5-B611B23FF1EAQ95635022-01965D69-0DCF-4D9B-9A3F-42F28CDCE9C1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
N Oreshkova
@en
N Oreshkova
@nl
type
label
N Oreshkova
@en
N Oreshkova
@nl
prefLabel
N Oreshkova
@en
N Oreshkova
@nl
P31
P496
0000-0001-8830-7055